- US - Thermo Fisher Scientific
Thermo Scientific products help scientists around the world meet the challenges they face every day From routine analysis to pioneering discoveries, our innovations help scientists solve complex analytical challenges, empowering them to conduct the work they need to do, the way they want to do it
- Thermo Scientific Products - Fisher Sci
Find Thermo Scientific research and production instruments, equipment, chemicals, consumables, and more to help you solve your analytical challenges every day
- Thermo Fisher Scientific - Wikipedia
Thermo Fisher Scientific Inc is an American life science and clinical research company It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services
- Shop All Products | Thermo Fisher Scientific - US
Browse our complete online catalog of analytical instruments, laboratory equipment and supplies, and protein, cell and molecular biology reagents and assays
- TMO | Thermo Fisher Scientific Inc. Stock Overview (U. S. : NYSE . . .
Complete Thermo Fisher Scientific Inc stock information by Barron's View real-time TMO stock price and news, along with industry-best analysis
- Thermo Fisher Scientific deepens investment in Asia’s biopharma . . .
Thermo Fisher Scientific (TMO) is expanding its bioprocessing operations in Asia amid the region’s rapidly growing biopharmaceutical industry, the company said on Tuesday The company is
- Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma . . .
Thermo Fisher’s continued investment across the region supports this growth, enabling customers with access to world-class technologies, expertise and localized support to accelerate the delivery of life-changing therapies
- Thermo Fisher Scientific’s Oncomine Dx Target Test receives FDA approval
Thermo Fisher Scientific has received approval from the U S Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic (CDx) to identify patients who may be eligible for treatment with HYRNUO™ (sevabertinib), a new HER2-directed therapy developed and commercialized by Bayer
|